NCT03917381

Open on CT.gov ↗

Primary endpoint removed: Dose Escalation and Monotherapy Expansion Cohorts: Number of Participants With Shifts From Baseline in Safety Laboratory Parameters — PHASE1
NCT03917381 • Phase 1